載入...
The neoepitope landscape of breast cancer: implications for immunotherapy
BACKGROUND: Cancer immunotherapy with immune checkpoint blockade (CKB) is now standard of care for multiple cancers. The clinical response to CKB is associated with T cell immunity targeting cancer-induced mutations that generate novel HLA-binding epitopes (neoepitopes). METHODS: Here, we developed...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6399957/ https://ncbi.nlm.nih.gov/pubmed/30832597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5402-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|